Compounded BPC-157 would be prepared by a licensed pharmacy under physician prescription, a separate regulatory pathway that depends on the FDA finalizing 503A listing
Look for third-party testing, 97-99% purity, proper packaging
Hu B, Ge X, Wang LF, Shi Z
Nonetheless, there remains an ongoing need for additional medicines, particularly those with a distinct mode of action that could be used independently or in combination with the current incretin-based therapeutics
When growth hormone receptors become more abundant on cell surfaces, each molecule of circulating growth hormone produces a stronger effect
The highest dose arms demonstrated significantly greater weight loss than liraglutide 3.0 mg administered daily (~10.8% vs ~9.0%)